These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2471009)

  • 1. Mechanisms of selective alpha1-inhibition in lipid metabolism. Role of doxazosin. Proceedings of an international workshop. Puerto Rico, April 16, 1988.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S1-52. PubMed ID: 2471009
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N; Benning CM
    Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of prazosin- and doxazosin-related compounds with modified piperazine ring.
    Giardinà D; Crucianelli M; Marucci G; Melchiorre C; Polidori C; Pompei P; Massi M
    Arzneimittelforschung; 1996 Nov; 46(11):1054-9. PubMed ID: 8955864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the lipid response to selective alpha 1-inhibition.
    Dzau VJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S50-2; discussion S52. PubMed ID: 2471017
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid metabolism: effects of selective alpha 1-inhibition. Proceedings of an international workshop. Washington, D.C., September 18, 1986.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S1-46. PubMed ID: 2447433
    [No Abstract]   [Full Text] [Related]  

  • 7. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Benning CM; Kyprianou N
    Cancer Res; 2002 Jan; 62(2):597-602. PubMed ID: 11809715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of doxazosin on lipid transport in rats and hamsters.
    Ontko JA; Woodside WF
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S31-6; discussions 36-7. PubMed ID: 2471013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical settings for selective alpha-adrenergic receptor inhibition: rationale and management strategies. Proceedings of a symposium. Naples, Florida, October 13 to 16, 1988.
    Am J Med; 1989 Aug; 87(2A):1S-66S. PubMed ID: 2569821
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reduction of coronary risk factors with selective alpha-blockers. International Doxazosin Symposium. Frankfurt/Main, 7 June 1986].
    Fortschr Med Suppl; 1986; 8():1-19. PubMed ID: 2876941
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade.
    González-Juanatey JR; Iglesias MJ; Alcaide C; Piñeiro R; Lago F
    Circulation; 2003 Jan; 107(1):127-31. PubMed ID: 12515754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats.
    Altan-Yaycioglu R; Yaycioglu O; Tufan H; Akova YA; Ozkardes H
    Curr Eye Res; 2007 Mar; 32(3):217-21. PubMed ID: 17453941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A; Kyprianou N
    Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatic cholesterol synthesis by the alpha 1-adrenoceptor blocker doxazosin in the hypercholesterolemic golden hamster.
    Jansen H; Lammers R; Baggen MG; Penders JM; Birkenhäger JC
    Life Sci; 1989; 44(15):1013-7. PubMed ID: 2564614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of serum lipids in hypercholesterolaemic rabbits treated with doxazosin.
    Leren TP; Berg K
    Scand J Clin Lab Invest; 1988 Jun; 48(4):313-7. PubMed ID: 2907180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin increases low density lipoprotein receptor activity.
    Leren TP
    Acta Pharmacol Toxicol (Copenh); 1985 Mar; 56(3):269-72. PubMed ID: 2861710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
    Swindell AC; Valentine JJ
    Am J Cardiol; 1987 May; 59(14):29G-34G. PubMed ID: 2884850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.